Heat Biologics, Inc. Presents Proprietary Allogeneic Cell Line…

Heat Biologics, Inc. Presents Proprietary Allogeneic Cell Line…

Taylor H. Schreiber, Ph.D., Vice President of Research and Development at Heat Biologics, presented the results of the Company’s translational research project entitled “Allogeneic Cell Based Vaccine Development by Shared Antigen Screening”.

Source: www.topix.com Via newsmixx: home News